BVF Partners

BVF Partners L.P. is a San Francisco-based private investment partnership that specializes in fundamentally-driven investments in the biotechnology sector. The firm focuses on building concentrated, long-term positions in small-cap public biotechnology companies, employing rigorous scientific and financial due diligence to identify undervalued opportunities across the drug development spectrum. BVF Partners maintains a value-focused philosophy with a long-term horizon, allowing it to navigate short-term market volatility and capitalize on asymmetric risk-reward profiles in biotech.

Founded in 1993 by Mark Lampert, BVF Partners emerged as a hedge fund manager dedicated to the biotechnology space. Headquartered in San Francisco, the firm was established to leverage deep fundamental research through networks of clinicians, industry veterans, and management teams. Over three decades, BVF has cultivated a reputation as a reliable partner to portfolio companies, often holding 25 to 30 core positions with significant concentration in top holdings.

BVF Partners has a track record of notable investments in innovative biotech firms, including recent participations in Series A rounds like Merida Biosciences and Ambrosia Biosciences, as well as Seed VC in Expedition Therapeutics and follow-on rounds in Numab Therapeutics. The firm has also engaged in pre-IPO share acquisitions, such as in Molecular Partners, and supports companies advancing novel therapeutics in areas like oncology, ophthalmology, and GPCR-targeted therapies. Portfolio exits include IPOs and acquisitions, demonstrating the firm's ability to generate value in dynamic biotech markets.

The team at BVF Partners brings specialized expertise in life sciences and biotechnology, led by founder Mark Lampert. With a research-intensive approach, the firm conducts ongoing monitoring and occasionally adopts activist strategies to enhance shareholder value. BVF serves institutional investors and family offices, managing vehicles like the Biotechnology Value Fund with a commitment to trustworthy partnerships in the sector.